GlassScriptPhysician profile
Melanie D Ward
NPI 1740571504
$9,013.35
in general payments reported to CMS, 2019-2025
17 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $3,766 · 2021: $3,632 · 2022: $493 · 2023: $415 · 2024: $129 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.53 |
| Education | $184.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $2,233.33 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $1,962.35 | 2019-2025 | |
| Genentech, INC. | $1,634.85 | 2021 | |
| Celgene Corporation | $1,440.00 | 2020 | |
| Biogen, INC. | $427.05 | 2019-2023 | Vumerity |
| Alexion Pharmaceuticals, INC. | $254.23 | 2019-2024 | Ultomiris, Soliris |
| Tg Therapeutics, INC. | $203.20 | 2023-2025 | |
| Genzyme Corporation | $194.27 | 2020-2022 | |
| Horizon Therapeutics Plc | $171.10 | 2022-2023 | Uplizna |
| Genentech USA, INC. | $107.56 | 2020 | |
| Abbvie INC. | $103.89 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $95.24 | 2022 | |
| Amgen INC. | $68.58 | 2025 | Uplizna |
| Ucb, INC. | $42.98 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $40.57 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18.45 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.